James R Klinger

14PUBLICATIONS

30CO-AUTHORS

Respiratory diseasesGene and molecular therapyPharmacogenomicsMajor global burdens of diseaseEpigenetics (incl. genome methylation and epigenomics)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jun 04, 2026

Identification of drug candidates for rescue of SOX17 gene targets in pulmonary arterial hypertension.

|May 15, 2026

Exploring the Lung-Liver Axis in Pulmonary Arterial Hypertension.

|Nov 26, 2025

Individualized Interactomes from Pulmonary Arterial Hypertension Cell Biopsies Predict Therapeutic Response.

Rui-Sheng Wang, Navneet Singh, Henri Wathieu

|Nov 17, 2025

American Lung Association Pulmonary Hypertension Roundtable: Executive Summary.

Nicholas Andreas Kolaitis, Sandeep Sahay, Erika Berman Rosenzweig

|Aug 18, 2025

Predicting Response to Switching From Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients With Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE Studies.

James R Klinger, Hikmet Al-Hiti, Sung-A Chang

|Aug 06, 2025

Effects of Dehydroepiandrosterone in Pulmonary Hypertension (EDIPHY): A Randomized, Double-Blind, Placebo-Controlled Crossover Trial.

Rachel Sanders, Thomas Walsh, Grayson L Baird

Pageof 3

Frequent Collaborators

Olin D Liang

Corey E Ventetuolo

Navneet Singh

Christopher J Rhodes

Jurjan Aman

Lan Zhao

Martin R Wilkins

Inês Cebola

Peter J Quesenberry

Elizabeth O Harrington

Frequent Collaborators

Olin D Liang

Corey E Ventetuolo

Navneet Singh

Christopher J Rhodes